VIDEO: Clinical trials show efficacy of Vevye for dry eye disease
BOSTON — In this Healio Video Perspective from the ASCRS meeting, Alice T. Epitropoulos, MD, FACS, discusses Vevye, a cyclosporine solution that treats signs and symptoms of dry eye disease.
Epitropoulos said Vevye (Harrow) is “the most potent cyclosporine commercially available at 0.1%,” but it is tolerable, comfortable and efficacious, adding that it has been shown to remain in the tears for up to 8 hours.
“Of the 1,100 subjects involved in the FDA clinical trials, 57% demonstrated an improvement in total corneal fluorescein staining at day 15, and 66% demonstrated an improvement at day 29,” Epitropoulos said. “Patients saw an average of 98% increase in tear production at 56 weeks.”
Collapse
Healio Interviews
Read more about